Advancing Biologics in Immunology
Vial is advancing first and best-in-class biologics to treat unmet need in Immunology & Inflammation
AI Designed Therapeutics
TARGET DISCOVERY
MOLECULE DESIGN
Rapid Experimental Validation
Vial is advancing best-in-class RNA, antibody, and small molecule programs with the following approach:
TARGET DISCOVERY
1
Target Discovery
Vial evaluates target biology and pre-clinical and clinical datasets to identify high-value therapeutic targets.
MOLECULE DESIGN
2
Molecule Design
Molecular designs are generated, evaluated, and optimized through iterative design loops to ultimately advance a development candidates.
Rapid Experimental Validation
3
Experimental Validation
Vial is enabled by high-throughput approaches to validate programs and accelerate development.
Automated Clinical Trials
Programs are evaluated in clinical trials powered by Vial’s clinical trial platform.
Focus Areas
Immunology
Contact
Get in touch
"*" indicates required fields
